Skip to content

Clinical trials

Phase 4 Endocarditis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocarditis Phase: Phase 4 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20081
20092
20112
20131
20141
20172
20211
20222
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6
Completed5
Unknown status4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Rigshospitalet, Denmark2
University of Santiago de Compostela2
Asan Medical Center1
Assistance Publique - Hôpitaux de Paris1
Carmen Olmos Blanco1
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Fundacion Clinic per a la Recerca Biomédica1
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla1
Henry Ford Health System1
Hospices Civils de Lyon1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocarditis18
Bacteremia3
Endocarditis, Bacterial2
Acute Kidney Injury1
Anemia1
Arthritis, Infectious1
Endocarditis, Subacute Bacterial1
Febrile Neutropenia1
Gram-Positive Bacterial Infections1
Inflammation1

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.